Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial

被引：0
|
作者：
In-Jae Oh
Kyu-Sik Kim
Cheol-Kyu Park
Young-Chul Kim
Kwan-Ho Lee
Jin-Hong Jeong
Sun-Young Kim
Jeong-Eun Lee
Kye-Chul Shin
Tae-Won Jang
Hyun-Kyung Lee
Kye-Young Lee
Sung-Yong Lee
机构：
[1] Chonnam National University Hwasun Hospital,Department of Internal Medicine, Lung and Esophageal Cancer Clinic
[2] Yeungnam University Medical Center,Department of Internal Medicine
[3] Yeungnam University College of Medicine,Department of Internal Medicine
[4] Chungnam National University Hospital,Department of Internal Medicine
[5] Chungnam National University School of Medicine,Department of Internal Medicine
[6] Yonsei University Wonju Severance Christian Hospital,Department of Internal Medicine
[7] Yonsei University College of Medicine,Department of Internal Medicine
[8] Kosin University Gospel Hospital,Department of Internal Medicine
[9] Kosin University College of Medicine,undefined
[10] Inje University Busan Paik Hospital,undefined
[11] Konkuk University Medical Center,undefined
[12] Konkuk University School of Medicine,undefined
[13] Guro Hospital,undefined
[14] Korea University,undefined
来源：
BMC Cancer | / 16卷
关键词：
Small cell lung carcinoma; Extensive stage disease; Phase III study; Chemotherapy; First-line; Belotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer
    Sun, Yan
    Cheng, Ying
    Hao, Xuezhi
    Wang, Jie
    Hu, Chengping
    Han, Baohui
    Liu, Xiaoqing
    Zhang, Li
    Wan, Huiping
    Xia, Zhongjun
    Liu, Yunpeng
    Li, Wei
    Hou, Mei
    Zhang, Helong
    Xiu, Qingyu
    Zhu, Yunzhong
    Feng, Jifeng
    Qin, Shukui
    Luo, Xiaoyan
    BMC CANCER, 2016, 16
  • [22] Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer
    Araujo, Antonio M. F.
    Mendez, Jose C.
    Coelho, Ana L.
    Sousa, Berta
    Barata, Fernando
    Figueiredo, Ana
    Amaro, Teresina
    Azevedo, Isabel
    Soares, Marta
    CANCER INVESTIGATION, 2009, 27 (04) : 391 - 396
  • [23] Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer
    Zhou, Zheng-tao
    Zhou, Fu-xiang
    Wei, Qing
    Zou, Li-yong
    Qin, Bin-fang
    Peng, Xu-shen
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (04) : 1027 - 1032
  • [24] Phase II study of Celecoxib with Cisplatin plus Etoposide in extensive-stage small cell lung cancer
    Araujo, Antonio M. F.
    Mendez, J. Carlos
    Sousa, Berta A.
    Barata, Fernando
    Figueiredo, Ana
    Azevedo, Isabel M.
    Amaro, Teresina
    Sousa, Maria J.
    Costa, Carla
    Lopes, J. MaChado
    ANNALS OF ONCOLOGY, 2004, 15 : 191 - 191
  • [25] Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer
    Araujo, Antonio M. F.
    Mendez, Jose C.
    Sousa, Berta
    Barata, Fernando
    Figueiredo, Ana
    Amaro, Teresina
    Coelho, Ana
    Azevedo, Isabel
    Soares, Marta
    ANNALS OF ONCOLOGY, 2006, 17 : 232 - 232
  • [26] Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer
    Zheng-tao Zhou
    Fu-xiang Zhou
    Qing Wei
    Li-yong Zou
    Bin-fang Qin
    Xu-shen Peng
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1027 - 1032
  • [27] A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
    Zatloukal, P.
    Cardenal, F.
    Szczesna, A.
    Gorbunova, V.
    Moiseyenko, V.
    Zhang, X.
    Cisar, L.
    Soria, J. -C.
    Domine, M.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2010, 21 (09) : 1810 - 1816
  • [28] A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
    Berghmans, Thierry
    Scherpereel, Arnaud
    Meert, Anne-Pascale
    Giner, Vicente
    Lecomte, Jacques
    Lafitte, Jean-Jacques
    Leclercq, Nathalie
    Paesmans, Marianne
    Sculier, Jean-Paul
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [29] Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: A University of Colorado Cancer Center Study
    Bunn, PA
    Kelly, K
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 11 - 15
  • [30] Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma - A Phase II trial of the North Central Cancer Treatment Group
    Jett, JR
    Hatfield, AK
    Hillman, S
    Bauman, MD
    Mailliard, JA
    Kugler, JW
    Morton, RF
    Marks, RS
    Levitt, R
    CANCER, 2003, 97 (10) : 2498 - 2503
12345